Clinical Stage IV Gastric Cancer AJCC v8 Recruiting Phase 2 Trials for Talazoparib (DB11760)

IndicationStatusPhase
DBCOND0113387 (Clinical Stage IV Gastric Cancer AJCC v8)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04550494Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair VariationsTreatment